1. Home
  2. NWN vs OGN Comparison

NWN vs OGN Comparison

Compare NWN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWN

Northwest Natural Holding Company

HOLD

Current Price

$46.77

Market Cap

2.0B

Sector

Utilities

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$9.63

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWN
OGN
Founded
1859
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NWN
OGN
Price
$46.77
$9.63
Analyst Decision
Buy
Hold
Analyst Count
2
5
Target Price
$49.50
$14.10
AVG Volume (30 Days)
241.2K
6.3M
Earning Date
02-27-2026
02-12-2026
Dividend Yield
4.18%
0.83%
EPS Growth
20.18
N/A
EPS
2.47
1.91
Revenue
$1,266,082,000.00
$6,301,000,000.00
Revenue This Year
$15.18
N/A
Revenue Next Year
$6.55
N/A
P/E Ratio
$19.04
$5.02
Revenue Growth
11.27
N/A
52 Week Low
$38.94
$6.18
52 Week High
$49.63
$17.23

Technical Indicators

Market Signals
Indicator
NWN
OGN
Relative Strength Index (RSI) 50.37 82.71
Support Level $46.35 $8.17
Resistance Level $47.16 $9.64
Average True Range (ATR) 0.78 0.44
MACD 0.06 0.19
Stochastic Oscillator 58.31 95.10

Price Performance

Historical Comparison
NWN
OGN

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: